Search Results - E. I. Kovalenko

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
    Hormone therapy for premenopausal women with metastatic breast cancer: combinations with cyclin-dependent kinase inhibitors

    Hormone therapy for premenopausal women with metastatic breast cancer: combinations with cyclin-dependent kinase inhibitors by E. V. Artamonova, E. I. Kovalenko

    Published 2019-09-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Increased proliferative response of highly differentiated CD57<sup>+</sup>NKG2C<sup>+</sup>NK cells expressing NKG2A

    Increased proliferative response of highly differentiated CD57<sup>+</sup>NKG2C<sup>+</sup>NK cells expressing NKG2A by N. A. Alekseeva, Yu. D. Vavilova, E. I. Kovalenko

    Published 2024-09-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    NK cells expansion <i>in vitro</i> is followed by loss of inhibitory KIR expression

    NK cells expansion <i>in vitro</i> is followed by loss of inhibitory KIR expression by N. A. Alekseeva, M. O. Ustyuzhanina, M. A. Streltsova, M. V. Grechikhina, G. V. Lutsenko, E. I. Kovalenko

    Published 2023-06-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    CDK4/6 inhibitors in the treatment of metastatic breast cancer. Choosing optimal therapy for estrogen-receptor-positive HER2-negative metastatic breast cancer: analysis of doctors’ preferences (“Prometheus”) in Russia – first results of the survey

    CDK4/6 inhibitors in the treatment of metastatic breast cancer. Choosing optimal therapy for estrogen-receptor-positive HER2-negative metastatic breast cancer: analysis of doctors’... by E. V. Artamonova, E. I. Kovalenko, L. V. Bolotina, M. B. Stenina, R. V. Orlova, M. A. Mukhina

    Published 2021-01-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    Effectiveness of cyclin-dependent kinase 4 and 6 inhibitors for the treatment of hormonesensitive HER2-negative metastatic breast cancer in first-line therapy: A systematic literature review

    Effectiveness of cyclin-dependent kinase 4 and 6 inhibitors for the treatment of hormonesensitive HER2-negative metastatic breast cancer in first-line therapy: A systematic literat... by N. A. Avxentyev, I. I. Andreyashkina, E. V. Artamonova, L. V. Bolotina, E. I. Kovalenko, N. N. Sisigina

    Published 2024-05-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    Coordination of NK cell markers expression and IgG response in hCMV infection

    Coordination of NK cell markers expression and IgG response in hCMV infection by M. O. Ustiuzhanina, Ju. D. Vavilova, N. A. Alekseeva, G. V. Lutcenko, D. M. Chudakov, E. I. Kovalenko

    Published 2023-06-01
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    DISTRIBUTION OF <i>MICA</i> ALLELES IN THE RUSSIAN POPULATION

    DISTRIBUTION OF <i>MICA</i> ALLELES IN THE RUSSIAN POPULATION by L. M. Kanevskiy, M. V. Grechikhina, E. G. Kuzmina, T. Yu. Mushkarina, A. A. Spelkov, M. A. Streltsova, E. I. Kovalenko

    Published 2019-12-01
    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    CIRCULATING MICA PROTEIN IN PATIENTS WITH MALIGNANT LYMPHOMAS

    CIRCULATING MICA PROTEIN IN PATIENTS WITH MALIGNANT LYMPHOMAS by A. V. Klinkova, E. G. Kuzmina, E. V. Abakushina, L. M. Kanevskiy, G. S. Neprina, V. V. Pavlov, E. I. Kovalenko

    Published 2016-04-01
    Get full text
    Article

    Save to List
    Saved in:
  9. 9
    Analysis of the association of the polymorphism of the CLIC1, MSH5, C6orf26, C6orf25 genes with the expression level of the HSPA1B gene

    Analysis of the association of the polymorphism of the CLIC1, MSH5, C6orf26, C6orf25 genes with the expression level of the HSPA1B gene by Yu. D. Vavilovа, A. A. Boyko, E. I. Kovalenko, M. V. Grechikhina, O. A. Shustova, T. L. Azhikina, A. M. Sapozhnikov

    Published 2020-08-01
    Get full text
    Article

    Save to List
    Saved in:
  10. 10
    Clinical significance of changes in the expression level of markers of surrogate breast cancer subtypes in recurrent and metastatic foci (literature review)

    Clinical significance of changes in the expression level of markers of surrogate breast cancer subtypes in recurrent and metastatic foci (literature review) by Yu. S. Krumin, V. A. Khaylenko, N. A. Kozlov, G. Yu. Cheremis, A. V. Petrovskyy, D. V. Khaylenko, E. V. Artamonova, E. I. Kovalenko

    Published 2021-03-01
    Get full text
    Article

    Save to List
    Saved in:
  11. 11
    Umbilical cord blood as a promising source of NK cells for immunotherapy

    Umbilical cord blood as a promising source of NK cells for immunotherapy by R. A. Velichinskii, J. D. Vavilova, A. A. Boyko, O. A. Shustova, A. I. Palamarchuk, G. M. Yusubalieva, O. N. Kucherova, M. A. Streltsova, E. I. Kovalenko

    Published 2023-06-01
    Get full text
    Article

    Save to List
    Saved in:
  12. 12
    TREATMENT OF BREAST CANCER WITH METASTATIC CONTRALATERAL AXILLARY LYMPH NODES: CASE REPORT AND LITERATURE REVIEW

    TREATMENT OF BREAST CANCER WITH METASTATIC CONTRALATERAL AXILLARY LYMPH NODES: CASE REPORT AND LITERATURE REVIEW by V. A. Amosova, A. V. Petrovsky, M. V. Chernykh, E. I. Kovalenko, M. A. Frolova, R. K. Valiev, M. I. Nechushkin, V. U. Kirsanov, I. V. Vysotskaya, D. E. Avtomonov

    Published 2020-01-01
    Get full text
    Article

    Save to List
    Saved in:
  13. 13
    Microenvironment-related predictive markers of the therapeutic effectiveness of eribulin in patients with locally advanced or metastatic breast cancer: pilot study

    Microenvironment-related predictive markers of the therapeutic effectiveness of eribulin in patients with locally advanced or metastatic breast cancer: pilot study by L.  A. Tashireva, N. O. Popova, V. V. Alifanov, V. E.  Goldberg, E. I. Kovalenko, E. V. Artamonova, A. G.  Manikhas, D. M. Ponomarenko, N. V. Levchenko, E. I. Rossokha, S. Yu.  Krasilnikova, M. A. Zafirova, V. M.  Perelmuter

    Published 2022-01-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: